|
Eugin Clinic (Clínica Eugin) is a fertility centre specialising in helping women and couples overcome difficulties in having children, thanks to Assisted Human Reproduction. Approved by the Spanish Ministry of Health and the Generalitat of Catalonia, the regional government, it's headquartered in Barcelona. Since 2015, Eugin Clinic has belonged to the NMC Health care group, which is the owner of several health centres in the United Arab Emirates and is listed on the London Stock Exchange. Currently, the clinic offers its services in Barcelona, Bogotá and Modena (Italy). Eugin Clinic has a large egg bank, and specializes in assisted reproduction treatments with these donated gametes. It was a pioneer in Spain in implementing the electronic double security system IVF Witness, ensuring the identification of the patient's eggs, which in practice eliminates the risk of confusion during treatment. In the autonomous community of Catalonia, Eugin Clinic represented 30% of all treatments performed in this field in 2015. ==History== In 1999, the clinic was founded in Barcelona by Dr. Mario Reverter Calatayud and Dr. Oriol Coll Escursell, both of whom are gynaecologists and specialists in Assisted Human Reproduction. In September 2007 the Eugin Foundation was established in order to serve as a framework for the teaching and research conducted through the centre. The Foundation's main goal is the study of fertility and human reproduction, both in their personal and social dimensions as well as in their clinical and health promotion aspects through the analysis, research and dissemination of this knowledge. Much of this research is conducted in Eugin's own laboratory in the Barcelona Scientific Park, which is their research centre affiliated with the University of Barcelona. The laboratory specializes in the cellular and molecular biology of reproduction, and focuses its research on determining the causes of infertility. In 2015, both entities presented a paper, at the European Society of Human Reproduction and Embryology (ESHRE), aimed at understanding the molecular changes in eggs. In 2012, Eugin Clinic achieved the birth of the first baby in the world born to a father suffering from a double chromosomal translocation. Having detected the alteration, the woman underwent ovarian stimulation and up to three cycles of IVF, all in the space of a year, in order to obtain embryos without genetic alterations, for which the pre-implantation genetic diagnosis technique was then used. For the analysis of the embryos a modification of the comparative genomic hybridization (CGH) technique was used that was developed with the Universitat Autònoma de Barcelona and which, for the first time, enabled them to analyse all the chromosomes of the embryo, not just 11, which the available techniques up to that time could only manage. After three cycles of IVF with PGD it was only in the third cycle that they finally succeeded in obtaining an embryo without genetic alterations that could be transferred to the mother, thus achieving a healthy embryo that resulted in the birth of the first baby born using this technique. In 2015, Eugin Clinic published a paper in Human Reproduction, endorsed by the ESHRE, where it is shown that the effectiveness of the use of stem cells for fertility treatments is unproven. Eugin Clinic has partnership agreements with prestigious European universities such as the University of Milan, the University of Ghent, Cardiff University and the University of Leeds where key aspects of assisted reproduction are investigated. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Clínica Eugin」の詳細全文を読む スポンサード リンク
|